SCHEMBL8102771

SCHEMBL8102771

CC1(C)CCC(C)(C)c2cc(N(C(=O)CN)c3ccc(C(=O)OCc4ccccc4)cc3)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
MAPT P10636 4/20 0.51
HPGD P15428 3/20 0.51
RXRA P19793 8/20 0.46
RXRB P28702 7/20 0.46
RXRG P48443 7/20 0.46
LMNA P02545 1/20 0.44
KMT2A Q03164 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CYP26B1 Q9NR63 2/20 0.43
RARB P10826 3/20 0.43
RARG P13631 3/20 0.43
RARA P10276 1/20 0.43
KDM4E B2RXH2 3/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 2/20 0.40
CYP3A4 P08684 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8106419 0.86 MAPT (0.47) ALDH1A1MAPTHPGDRXRARXRB
SCHEMBL8093051 0.84 RXRA (0.64) RXRARXRBRXRGRARBRARG
SCHEMBL8102921 0.81 RXRA (0.51) ALDH1A1RXRARXRBRXRGLMNA
SCHEMBL8839024 0.81 KMT2A (0.56) ALDH1A1MAPTHPGDRXRARXRB
SCHEMBL8103047 0.79 RXRA (0.47) RXRARXRBRXRGCYP26B1RARB
SCHEMBL9551719 0.77 RARB (0.54) ALDH1A1MAPTHPGDRXRARXRB
SCHEMBL8556010 0.75 RXRA (0.49) RXRARXRBRXRGCYP26B1RARB
SCHEMBL8102485 0.74 RXRA (0.64) ALDH1A1RXRARXRBRXRGKMT2A
SCHEMBL8558866 0.74 RXRA (0.48) ALDH1A1RXRARXRBRXRGKMT2A
SCHEMBL6144299 0.74 ALDH1A1 (0.45) ALDH1A1MAPTHPGDRXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed